Now live: Pro — the full 13F research suite for serious investorsSee pricing →
UNIVERSITY OF CHICAGO

Q3 2024 · 13F-HR

UNIVERSITY OF CHICAGOholdings as filed

Filed 2024-10-16 · accession 0001104659-24-108980

$118.3M
Reported value
5
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
921937835BNDVANGUARD BD INDEX FDS TOTAL BND MRKT$41.5M35.1%552,830CommonSOLE
922042742VTVANGUARD INTL EQUITY INDEX F$40.2M34.0%335,471CommonSOLE
922908363VOOVANGUARD INDEX FDS$36.2M30.6%68,413CommonSOLE
65488A101NKGNNKGEN BIOTECH INC$207,9000.18%550,000CommonSOLE
747324101PYXSPYXIS ONCOLOGY INC$178,8430.15%48,731CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.